Approval · Notice of Compliance 8665 · 2007
RAPAMUNE: Notice of Compliance 8665
Issued March 23, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8665
- Date
- March 23, 2007
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use in combination with cyclosporine for the prophylaxis of organ rejection in high-risk renal transplant recipients
- Therapeutic class
- Immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPAMUNE | Not yet assigned | — |